Go Pro

Pharvaris (PHVS) 10K Form and Latest SEC Filings 2026

Pharvaris logo
$35.07 0.00 (0.00%)
Closing price 07/13/2026 04:00 PM Eastern
Extended Trading
$35.06 -0.02 (-0.04%)
As of 04:52 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Pharvaris SEC Filings & Recent Activity

Pharvaris (NASDAQ:PHVS) has submitted 210+ documents to the U.S. Securities and Exchange Commission (SEC) since 2021. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Pharvaris's financial statements. The most recent filing was a Form 144 submitted on July 13, 2026.

Form 4
Pharvaris N.V. Reports Ownership Change on Jul. 1, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

20-F
Pharvaris Files Annual Report on Apr. 2, 2026

The 20-F contains Pharvaris's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

Pharvaris SEC Filing History

Browse Pharvaris' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
07/13/2026 3:39 PM
Modig Berndt (1643072) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2026 6:02 PM
Lesage Anne (1973705) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 6:06 PM
Pharvaris (1830487) Issuer
Schikan Johannes Gerardus Christiaan Petrus (2014983) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2026 3:36 PM
Pharvaris (1830487) Subject
Schikan Johannes Gerardus Christiaan Petrus (2014983) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/30/2026 3:36 PM
Lesage Anne (1973705) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/30/2026 3:36 PM
Lesage Anne (1973705) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 5:41 PM
Lesage Anne (1973705) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2026 5:18 PM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2026 5:18 PM
Pharvaris (1830487) Issuer
Schikan Johannes Gerardus Christiaan Petrus (2014983) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2026 3:45 PM
Lesage Anne (1973705) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 3:45 PM
Lesage Anne (1973705) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 3:49 PM
Pharvaris (1830487) Subject
Schikan Johannes Gerardus Christiaan Petrus (2014983) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2026 3:30 PM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2026 10:27 AM
Pharvaris (1830487) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2026 3:25 PM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/23/2026 4:07 PM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2026 3:28 PM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2026 4:51 PM
Modig Berndt (1643072) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2026 4:50 PM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2026 4:22 PM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2026 5:52 AM
Pharvaris (1830487) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/08/2026 1:53 PM
Nijdam Anna (1973872) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2026 5:21 PM
Nijdam Anna (1973872) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/26/2026 4:53 PM
Monges Viviane (1838204) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 4:42 PM
Nassif David W. (1636975) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 4:45 PM
Nijdam Anna (1973872) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2026 4:03 PM
Nijdam Anna (1973872) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2026 1:54 PM
Bjork Elisabeth (1810406) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2026 1:41 PM
Modig Berndt (1643072) Reporting
Pharvaris (1830487) Issuer
Form 4/A
05/21/2026 4:27 PM
Nassif David W. (1636975) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2026 4:31 PM
Monges Viviane (1838204) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2026 4:35 PM
Nijdam Anna (1973872) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2026 4:23 PM
Bjork Elisabeth (1810406) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2026 4:33 PM
Modig Berndt (1643072) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2026 3:30 PM
Glassman Robert (1897890) Reporting
Pharvaris (1830487) Subject
Form 144/A
05/19/2026 5:42 PM
Pharvaris (1830487) Issuer
Souverijns Wim (1973529) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2026 5:44 PM
Abele Stefan Andreas (2002390) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2026 5:48 PM
Glassman Robert (1897890) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2026 4:44 PM
Pharvaris (1830487) Subject
Souverijns Wim (1973529) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2026 4:48 PM
Pharvaris (1830487) Subject
VIKING GLOBAL INVESTORS LP (1103804) Filed by
Form SCHEDULE 13G/A
05/15/2026 4:50 PM
Abele Stefan Andreas (2002390) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump’s $250 Bill – See Immediately (Ad)

Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in modern history - larger than Paul Tudor Jones' Black Monday bet and Michael Burry's $700 million Big Short. While most investors chase AI stocks, insiders including Ray Dalio and Tudor Jones have quietly repositioned. The last comparable shock sent certain stocks up 2,464%, 2,778%, and even 13,000% - turning a $10,000 stake into over $1.3 million. Dr. Eifrig has identified one stock at the center of this story and released a free broadcast to help investors act before the window closes.tc pixel

Watch the free broadcast now and learn where to position your money
05/15/2026 3:31 PM
Modig Berndt (1643072) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2026 5:48 PM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2026 3:05 PM
Pharvaris (1830487) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/11/2026 3:41 PM
Pharvaris (1830487) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2026 4:13 PM
Pharvaris (1830487) Filer
Form 424B5
05/05/2026 2:51 PM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2026 6:30 PM
Lesage Anne (1973705) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2026 6:32 PM
Pharvaris (1830487) Issuer
Schikan Johannes Gerardus Christiaan Petrus (2014983) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2026 6:09 PM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2026 1:09 PM
Pharvaris (1830487) Issuer
Schikan Johannes Gerardus Christiaan Petrus (2014983) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2026 11:18 AM
Lesage Anne (1973705) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2026 10:27 AM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2026 4:17 PM
Lesage Anne (1973705) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/22/2026 3:28 PM
Pharvaris (1830487) Subject
Schikan Johannes Gerardus Christiaan Petrus (2014983) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/22/2026 3:29 PM
Lesage Anne (1973705) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/22/2026 3:29 PM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/20/2026 4:38 PM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2026 2:00 PM
Modig Berndt (1643072) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2026 3:15 PM
Modig Berndt (1643072) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/14/2026 4:52 PM
Nijdam Anna (1973872) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2026 12:42 PM
Modig Berndt (1643072) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2026 3:35 PM
Modig Berndt (1643072) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/08/2026 2:00 PM
Nijdam Anna (1973872) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 1:07 PM
Nijdam Anna (1973872) Reporting
Pharvaris (1830487) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 10:00 AM
Abele Stefan Andreas (2002390) Reporting
Pharvaris (1830487) Issuer
Form 3/A
04/02/2026 5:50 AM
Pharvaris (1830487) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2026 5:51 AM
Pharvaris (1830487) Filer
Form 20-F
Registration statement / Annual report / Transition report  
03/18/2026 1:23 PM
Deschoolmeester Annick (1973964) Reporting
Pharvaris (1830487) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 1:23 PM
Modig Berndt (1643072) Reporting
Pharvaris (1830487) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 1:23 PM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 1:23 PM
Monges Viviane (1838204) Reporting
Pharvaris (1830487) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 1:23 PM
Meeker David P (1385155) Reporting
Pharvaris (1830487) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 1:23 PM
Nijdam Anna (1973872) Reporting
Pharvaris (1830487) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 1:23 PM
Pharvaris (1830487) Issuer
Souverijns Wim (1973529) Reporting
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 1:23 PM
Lesage Anne (1973705) Reporting
Pharvaris (1830487) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 1:23 PM
Abele Stefan Andreas (2002390) Reporting
Pharvaris (1830487) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 1:23 PM
Nassif David W. (1636975) Reporting
Pharvaris (1830487) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 1:23 PM
Bjork Elisabeth (1810406) Reporting
Pharvaris (1830487) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 1:23 PM
Pharvaris (1830487) Issuer
Schikan Johannes Gerardus Christiaan Petrus (2014983) Reporting
Form 3
Initial statement of beneficial ownership of securities  
03/18/2026 1:23 PM
Glassman Robert (1897890) Reporting
Pharvaris (1830487) Issuer
Form 3
Initial statement of beneficial ownership of securities  
02/17/2026 3:30 PM
Bain Capital Life Sciences Fund, L.P. (1687968) Filed by
Pharvaris (1830487) Subject
Form SCHEDULE 13G/A
01/12/2026 5:51 AM
Pharvaris (1830487) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/02/2026 3:29 PM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2025 5:08 PM
Abele Stefan Andreas (2002390) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2025 5:56 AM
Pharvaris (1830487) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/12/2025 7:00 AM
Pharvaris (1830487) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2025 3:50 PM
Pharvaris (1830487) Filer
Form POSASR
09/08/2025 3:51 PM
Pharvaris (1830487) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2025 4:56 PM
Pharvaris (1830487) Subject
Venrock Healthcare Capital Partners III, L.P. (1738048) Filed by
Form SCHEDULE 13G/A
07/24/2025 5:17 AM
Pharvaris (1830487) Filer
Form 424B5
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
07/22/2025 8:03 PM
Pharvaris (1830487) Subject
Form FWP
07/14/2025 3:22 PM
Lu Peng (1972159) Reporting
Pharvaris (1830487) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Pharvaris SEC Filings - Frequently Asked Questions

Pharvaris (PHVS) has submitted 210+ filings to the SEC since 2021. You can browse the complete history or filter by form type using the tools above.

Pharvaris's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Pharvaris's financial statements page.

The most recent filing was a Form 144 submitted on July 13, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:PHVS) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners